Biotech & Pharma

It's time to place the blame for the nation's opioid epidemic squarely where it belongs, in Washington DC.

A slow start and a dearth of mergers and acquisitions made 2016 a tough year for biotech, but new gene and immuno-therapies are leading the way for a much stronger performance when 2017 results are in.

The Arkansas-based company will lease a 90,000-square-foot facility in Windsor, CT, where it will create approximately 361 new jobs over the next four years.

The May / June 2017 issue features our annual tour of the locations that are leaders in logistics and distribution, ports and FTZs, LiveXchange 2017, biotech, tourism, and certified sites. Plus, what’s going on in Maryland, Louisiana, Nevada and Tennessee.

The pharmaceutical company will invest $35 million to expand its Fairfax County, VA R&D and manufacturing operation.

As the IEDC's second annual celebratory week for Economic Development begins today, here are some tips about how your location can participate.

The Louisiana Proton Therapy Center will be housed on University Medical Center campus in city’s biomedical corridor.

Virbac Corporation will consolidate its distribution operations in a facility at Kansas City's Hunt Midwest SubTropolis to tap into the benefits provided by the KC Animal Health Corridor.

The pharmaceutical giant’s significant investment in manufacturing diabetes medicines will continue with a new $85 million commitment in Indianapolis.

The company will invest $59 million in the Lancaster County expansion project, which includes construction of a new facility and purchasing new state-of-the-art laboratory instrumentation and equipment.

The Lone Star State reaffirms its dominance as the most dynamic state economy in the U.S., an energy and exports powerhouse with a seemingly boundless potential for growth.

The third-party logistics firm will invest more than $3.7 million and create up to 50 new jobs at its Hendricks County facility this year.

Statewide legal marijuana is a $6.7-billion industry that may all go up in smoke if the Justice Department enforces federal laws prohibiting it.

The drug development company will add contract manufacturing services to its Bloomington, IN operations, creating up to 33 new jobs.

The 30,000-square foot facility — a collaborative effort by Johnson & Johnson Innovation, New York State and New York Genome Center — will have capacity for up to 30 life science startups focused on biotech, pharmaceutical, medical devices and consumer health.

The Lone Star State wins BF's top annual honor for the third time.

The pharmaceutical research and development facility will be located at the University of Louisiana at Lafayette affiliate.

The 100,000-square-foot building is the latest addition to the 152-acre HudsonAlpha Institute for Biotechnology campus in Huntsville, AL, and will house a mix of research laboratories and life sciences companies.

By the end of 2017, Alpha Genesis, Inc. will create up to 30 new jobs at its headquarters facilities in Yemassee, SC.

The company will invest more than $24.4M in two expansion projects, both in Montgomery County, with the help of a Pennsylvania First Program grant.

CTD Holdings will invest $2.75M and create 51 jobs at its new corporate headquarters in Jupiter, FL.

The 40 growing technology and biotech companies will share the New Jersey Technology Business Tax Certificate Transfer Program funds in FY2017.

A $1.8 million specialized biotech startup and a $10 million expansion of Coldstream Labs’ pharmaceutical plant are the most recent additions to Lexington’s growing biotech cluster.

The world's biggest biotechnology success story is having some unintended consequences.

Greater Rochester, NY is Business Facilities' top-ranked Innovation Hub; Albany, NY and Youngstown, OH placed second and third, respectively, in the magazine's 12th Annual Rankings Report.

Vetter plans to invest $320 million and create 300 jobs at its Des Plaines, IL manufacturing facility.

The world's scientists have been given the green light to re-engineer the human race. Anybody think that's a good idea?

The specialty generic pharmaceutical company is expanding its manufacturing and R&D complex in Buena, NJ, with the potential to create up to 200 jobs.

The Grow NJ program award targets job creation and will help the company grow in Vineland, yielding a net benefit of $20.4M back to the state over 20 years.

The Commercialization Center for Innovative Technologies (CCIT), the Garden State’s leading life sciences incubator, is a hub of activity within New Jersey’s technology sector.

The growing Montgomery County, MD clinical stage vaccine company is developing promising vaccines for RSV, influenza and Ebola.

The molecular diagnostics company is the newest tenant at the Prince William Science Accelerator in Innovation Park.

Graphene, the material that will revolutionize the world, is ready for its close-up in the commercial sector.

A $2.8-million investment from Innovate NY—matched by $21.5 million in private equity—is spurring the development of a biotech cluster in New York City.